Share

August 2016; 3 (4) ArticleOpen Access

Next-generation sequencing in neuropathologic diagnosis of infections of the nervous system

Steven L. Salzberg, Florian P. Breitwieser, Anupama Kumar, Haiping Hao, Peter Burger, Fausto J. Rodriguez, Michael Lim, Alfredo Quiñones-Hinojosa, Gary L. Gallia, Jeffrey A. Tornheim, Michael T. Melia, Cynthia L. Sears, Carlos A. Pardo
First published June 13, 2016, DOI: https://doi.org/10.1212/NXI.0000000000000251
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
2261

Share

Article Information

vol. 3 no. 4 e251
DOI: 
https://doi.org/10.1212/NXI.0000000000000251
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Online ISSN: 
2332-7812
History: 
  • Received February 4, 2016
  • Accepted in final form May 9, 2016
  • First Published June 13, 2016.
Copyright & Usage: 
© 2016 American Academy of Neurology This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND), which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially.

Author Disclosures

    1. Steven L. Salzberg, PhD,
    2. Florian P. Breitwieser, PhD,
    3. Anupama Kumar, MBBS,
    4. Haiping Hao, PhD,
    5. Peter Burger, MD,
    6. Fausto J. Rodriguez, MD,
    7. Michael Lim, MD,
    8. Alfredo Quiñones-Hinojosa, MD,
    9. Gary L. Gallia, MD,
    10. Jeffrey A. Tornheim, MD,
    11. Michael T. Melia, MD,
    12. Cynthia L. Sears, MD and
    13. Carlos A. Pardo, MD
  1. Steven L. Salzberg, PhD,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Associate Editor, Editorial Board member, or Editorial Advisory Board member for the following journals: Genome Biology, PeerJ Computer Science, BMC Biology, Biology Direct, Journal of Computational Biology, BMC Genomics, BMC Bioinformatics, Evolutionary Bioinformatics

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. National Institutes of Health, NHGRI, R01 HG006677, PI, 8/7/2015?6/30/2019 National Institutes of Health, NHLBI, R01 HL129239, PI, 07/01/2015?06/30/2018 National Institutes of Health, NIGMS, R01 GM083873, PI, 4/1/2014?3/31/2018

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Florian P. Breitwieser, PhD,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Anupama Kumar, MBBS,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Haiping Hao, PhD,
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Peter Burger, MD,
    6. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  6. Fausto J. Rodriguez, MD,
    7. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. Book: Diagnostic Neuropatology, second edition, Elsevier (2016)

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  7. Michael Lim, MD,
    8. Scientific Advisory Boards:

    1. 1. Novartis - DSMB 2. BMS 3. Stryker

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. 1. Stryker, honoraria and travel 2. BMS, honoraria and travel

    Editorial Boards:

    1. NONE

    Patents:

    1. 1. Methods patent for the combination of focused radiation and immunotherapy

    Publishing Royalties:

    1. 1. Handbook of Radiosurgery

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. 1. Stryker 2. BMS

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. 1. Neurosurgery - affect potentially number of surgeries performed

    Research Support, Commercial Entities:

    1. 1. Stryker - Research Support 2. BMS - Research Support 3. Aegenus - Research Support 4. CellDex- Research Support 5. Arbor - Research Support

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  8. Alfredo Quiñones-Hinojosa, MD,
    9. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. Speaker honoraria and travel funding paid from commercial entities Speak Inc. and American Program Bureau, Inc.

    Editorial Boards:

    1. Cancer Today, Editorial Advisory Board, 2015-Present

    Patents:

    1. 1. NKCC1-pcDNA3-GFP. Quinones-Hinojosa A, Aprhys C, Garzon-Muvdi T. JHU Ref. #C12074 2. Microfluid Assay for the Determination of Tumor Cell Metastatic Propensity. Konstantopoulos K, Paul C, Quinones-Hinojosa A, Kontrogianni-Konstantopoulos. JHU UMSOM Ref#C12511 3. A Novel, High-throughput, Nanotopographic Platform for Screening Cell Migratory Behavior. Christopher Smith, Andre Levchenko, Deok-Ho Kim, Quinones-Hinojosa A. JHU Ref. #C12838. PCT application number PCT/US2015/019692. 4.Quantitative Tissue Property Mapping for Real Time Tumor Detection and Interventional Guidance Li X, Chaichana K, Kut C, Mcveigh E, Quinones-Hinojosa A, Xi J. JHU Ref. #C12934. PCT application number PCT/US15/22432. 5. Nanoparticle Modification of Human Adipose-derived Mesenchymal Stem Cells for Brain Cancer and Other Neurological Diseases Quinones-Hinojosa A, Green J. JHU Ref. #C13152 6. Therapeutic Nanofiber Hydrogels for Local Treatment of Brain-Related Diseases. Cui H, Quinones-Hinojosa A. JHU Ref. #C13285 7. Methods for phenotypic classification of cells based on migratory behavior. Kilic O, Schiapparelli P, Quinones-Hinojosa A, Levchenko A. Ref. #C13721 8.Use of AGX/UAP Inhibitors to Inhibit Flux Through the Hexosamine Biosynthetic Pathway. Saeui C, Shah S, Quinones-Hinojosa A, Yarema K. Ref# C13122 9.Self-Assembling Verteporfin amphiphiles (SAVA) for local brain cancer therapy. Shah S, Martinez-Gutierrez JC, Ruiz-Valls A, Lin R, Cui H, Quinones-Hinojosa A. Ref# C13797. 10.Predicting brain tumor patient prognosis. Konstantopoulos K, Paul C, Martinez-Gutierrez JC, Ruiz-Valls A, Sheng Wong B, Yankaskas, Quinones-Hinojosa A. JHU Ref#C13906 11.NAAG is an indicator of clinical prognosis for glioblastoma Slusher B, Poore B, Lee A, Shah S, Quinones-Hinojosa A. JHU Ref# C14019

    Publishing Royalties:

    1. 1. Quinones-Hinojosa A, (chief ed), Schmidek and Sweet Operative Neurosurgical Techniques, 6e. (eds). Elsevier, 2012. 2. Quinones-Hinojosa A, Eichler M. Becoming Dr Q: My Journey from Migrant Farm Worker to Brain Surgeon. UC Press, 2011. 3. Quinones-Hinojosa A, Eichler M. Dr. Q: La Historia de Como un Jornalero Migrante se Convirtio en Neurocirujano. LID Espanol, 2013. 4. Quinones-Hinojosa A and Raza S., Controversies in Neuro-Oncology: Best Evidence Medicine for Brain Tumor Surgery. Thieme, 2013. 5. Oscar Gonzalez-Perez, Jose M. Garcia-Verdugo, Quinones-Hinojosa A, Sonia Luquin, Graciela Gudino-Cabrera, and Rocio E. Gonzalez-Castaneda (eds). ?Neural Stem Cells in the Adult Brain: From Benchside to Clinic? Stem Cells International Volume 2012. 6. Boahene K and Qui?ones-Hinojosa A. Minimal access skull base surgery: open and endoscopic assisted approaches. 1st edition. Ed. by Boahene and Qui?ones-Hinojosa. India: Jaypee Brothers Medical Publishers (P) LTD. 2016.

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. 1. Stryker 2. Integra

    Speakers' Bureaus:

    1. 1. Speak, Inc. 2. American Program Bureau, Inc.

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. 1. Stryker 2. Integra

    Research Support, Government Entities:

    1. 1. NIH, R01NS070024, Principal Investigator,8/1/2010 - 7/31/2015 2. NIH, Principal Investigator, 8/1/2015 - 7/31/2020 3. NIH, R01CA183827, P.I., 5/1/2015 - 4/31/2020 4. NIH/NCI, R01EB016721, Co-investigator, 1/1/2013 ? 12/31/20175. NIH/NCI, R01 CA166171, Co-investigator, 2/5/2013 - 1/31/2018 6. NIH/NCI, R01 CA166171, Co-investigator, 1/1/2011 - 6/31/2016

    Research Support, Academic Entities:

    1. 1. Johns Hopkins University

    Research Support, Foundations and Societies:

    1. 1. JHU Coulter Foundation 2. Maryland Stem Cell Research Fund (TEDCO) 3. Maryland Biotechnology Development Award 4. Allegheny Health Network-Johns Hopkins Cancer Research Fund

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  9. Gary L. Gallia, MD,
    10. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Chordoma Foundation

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  10. Jeffrey A. Tornheim, MD,
    11. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  11. Michael T. Melia, MD,
    12. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. I am a co-investigator for hepatitis C clinical trials conducted at my institution. Funding for these studies has been paid (by Merck, Sharpe & Dohme; Janssen; Gilead; Bristol-Myers Squibb; and AbbVie) to my institution.

    Research Support, Government Entities:

    1. 12/1/10-present?A Staged Phase I/II Study, to Assess Safety, Efficacy and Immunogenicity of a New Hepatitis C Prophylactic Vaccine Based on Sequential Use of AdCh3NSmut1 and MVA-NSmut? Sexually Transmitted Infections Clinical Trials NIH DMID HHSN266200400074C NIAID Total directs TBD; in excess of $10,000,000 PI: Andrea Cox Co-Investigator, effort 10%; A clinical trial of a novel prophylactic HCV vaccine in subjects at risk for HCV infection in which the immune response to the vaccine and correlates of protective immunity will be assessed.10/1/14 ? 9/30/18 ?Maryland Community Based Program to Test and Cure Hepatitis C? PS14-1413 CDC/MDHMH Total directs ~$1,200,000; JHU budget $347,383 per year PI: David Thomas (JHU), Lucy Wilson (MDHMH). (DHMH is the award recipient; JHU is a sub-recipient.) Co-Investigator, effort: 10%; A program designed to strengthen health care capacity to diagnose and cure hepatitis C virus (HCV) infection through implementation of a package of services in a target population with HCV-related health disparities.

    Research Support, Academic Entities:

    1. 7/1/15-12/31/16 The Johns Hopkins School of Medicine Institute for Excellence in Education $50,000 Principal investigator, 10% effort

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  12. Cynthia L. Sears, MD and
    13. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Clinical Infectious Diseases, Associate Editor, 2001-present

    Patents:

    1. Biofilms in colon cancer as diagnostic approach to identify individuals at risk for colon cancer.

    Publishing Royalties:

    1. UP-to-Date, reviewer for infectious diseases topics, 2010 to present

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. 1. R01CA179440, NIH, PI, 07/01/13-04/30/17 2. P30AI094189, NIH, project leader, 08/15/14-04/30/16 3. R01ES011858-23A1, NIH/NCI, co-investigator, 09/19/14-05/31/19 4. P30DK089502, NIH, co-investigator, 06/01/11-05/31/16 5. P50CA062924, NIH, project leader, 10/01/15-08/31/16 6. R01CA151393, NIH/NCI, PI, 09/02/10 ? 07/31/15 7. R01CA151325, NIH/NCI, PI, 7/06/10 ? 04/30/15

    Research Support, Academic Entities:

    1. 1. Johns HOpkins Medicine/Applied Physics Laboratory 2. Johns HOpkins SIIME Award

    Research Support, Foundations and Societies:

    1. 1. Institut Merieux

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  13. Carlos A. Pardo, MD
    14. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Accorda Pharmaceuticals, Clinical Trial, Co-investigator 2012-2014

    Research Support, Government Entities:

    1. NIH/NINDS R21NS076381, Role: Principal Investigator, 2012-2015 NIH/NIMH R01NS055628, Role: Principal investigator, 2008-2014 NIH/NINDS R21TW0009741, Role: Co-investigator 2013-2015 NIH-NIMH P30MH075673, Role: Co-Investigator 2005-2016

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Bart McLean Fund for Neuroimmunology Research-Project Restore

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Center for Computational Biology, McKusick-Nathans Institute of Genetic Medicine (S.L.S., F.P.B.), Department of Neurology (A.K., C.A.P.), Deep Sequencing and Microarray Core (H.H.), and Departments of Pathology (P.B., F.J.R., C.A.P.), Neurosurgery (M.L., A.Q.-H., G.L.G.), and Medicine (J.A.T., M.T.M., C.L.S.), School of Medicine, and Departments of Biomedical Engineering, Computer Science, and Biostatistics (S.L.S.), Johns Hopkins University, Baltimore, MD.
  1. Correspondence to Dr. Pardo: cpardov1{at}jhmi.edu
View Full Text

Article usage

Article usage: June 2016 to April 2019

AbstractFullPdfSource
Jun 2016644771212Highwire
Jun 201606032pmc
Jul 201624723077Highwire
Jul 2016010952pmc
Aug 2016455503131Highwire
Aug 201606225pmc
Sep 201614816056Highwire
Sep 201607034pmc
Oct 20168612731Highwire
Oct 201606121pmc
Nov 20168710324Highwire
Nov 201605721pmc
Dec 20169411722Highwire
Dec 201603211pmc
Jan 2017928237Highwire
Jan 201705826pmc
Feb 2017886432Highwire
Feb 201706117pmc
Mar 2017736629Highwire
Mar 201706815pmc
Apr 2017829240Highwire
Apr 2017356170pmc
May 2017734928Highwire
May 2017184752pmc
Jun 2017684935Highwire
Jun 201713212360pmc
Jul 2017523721Highwire
Jul 2017203644pmc
Aug 20171604135Highwire
Aug 2017235363pmc
Sep 2017523116Highwire
Sep 2017134144pmc
Oct 2017572321Highwire
Oct 2017226472pmc
Nov 2017537121Highwire
Nov 2017285453pmc
Dec 20171012016Highwire
Jan 2018313624Highwire
Feb 2018713120Highwire
Mar 2018613721Highwire
Apr 201898728Highwire
Apr 2018114452pmc
May 2018814022Highwire
Jun 2018311422Highwire
Jun 201883437pmc
Jul 2018711025Highwire
Aug 2018910726Highwire
Aug 201821134170pmc
Sep 2018711721Highwire
Oct 2018611342Highwire
Nov 20181218041Highwire
Dec 20181332720Highwire
Jan 2019821718Highwire
Feb 20192122624Highwire
Mar 20191318424Highwire
Apr 20191922328Highwire

Cited By...

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

NOTE: All contributors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.nn.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.

  • Stay timely. Submit only on articles published within the last 8 weeks.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • 200 words maximum.
  • 5 references maximum. Reference 1 must be the article on which you are commenting.
  • 5 authors maximum. Exception: replies can include all original authors of the article.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Letters

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Letters Submission Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top

Topics Discussed

Alert Me

Advertisement